Medik8
Liberty advises the management team of Medik8 on its acquisition by L’Oréal Groupe
Liberty Corporate Finance is delighted to announce they have advised the management team of Medik8, a premium British skincare brand, on its acquisition by L'Oréal Groupe, the French cosmetic giant. As part of the transaction, Inflexion, a leading European mid-market private equity firm, will retain a minority shareholding in Medik8.
Founded in 2009 by scientist Elliot Isaacs, Medik8 is a premium clinical skincare brand, offering high-quality active skincare products which deliver clinical results without compromising on experience. Best known for its iconic Crystal Retinal serum and its trademark CSA Philosophy®, Vitamin C and Sunscreen by Day, Vitamin A by night, Medik8 formulates and manufactures its products in-house in its UK Innovation Centre.
This acquisition further strengthens L’Oréal’s Luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success, with strong potential for global growth.
Throughout our deal we worked closely with Dan and the team at Liberty. From the start of the process and their help in explaining the options ahead of us in different deal types through to their availability through the final days and hours of the deal they were ideal partners for me and the management team at Medik8 and their advice and counsel was invaluable
Simon Coble
CEO of Medik8
We are delighted to have advised Simon and the entire Medik8 management team on this exciting next chapter for the business. We look forward to seeing the team’s continued success over the coming years as they strengthen their innovative capabilities and reach a wider audience.
Dan Martinez
Partner
+44 (0) 7398 212 298
[email protected]